DE69130845T2 - HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung - Google Patents

HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung

Info

Publication number
DE69130845T2
DE69130845T2 DE69130845T DE69130845T DE69130845T2 DE 69130845 T2 DE69130845 T2 DE 69130845T2 DE 69130845 T DE69130845 T DE 69130845T DE 69130845 T DE69130845 T DE 69130845T DE 69130845 T2 DE69130845 T2 DE 69130845T2
Authority
DE
Germany
Prior art keywords
hla
nucleotide sequence
antigen gene
antigen
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130845T
Other languages
English (en)
Other versions
DE69130845D1 (de
Inventor
Fiumiya Obata
Noboru Kashiwagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Chemicals Inc
Kitasato Institute
Original Assignee
Mitsui Chemicals Inc
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Chemicals Inc, Kitasato Institute filed Critical Mitsui Chemicals Inc
Application granted granted Critical
Publication of DE69130845D1 publication Critical patent/DE69130845D1/de
Publication of DE69130845T2 publication Critical patent/DE69130845T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69130845T 1990-08-20 1991-08-20 HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung Expired - Fee Related DE69130845T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21720990 1990-08-20

Publications (2)

Publication Number Publication Date
DE69130845D1 DE69130845D1 (de) 1999-03-18
DE69130845T2 true DE69130845T2 (de) 1999-06-10

Family

ID=16700579

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130845T Expired - Fee Related DE69130845T2 (de) 1990-08-20 1991-08-20 HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung

Country Status (5)

Country Link
US (1) US5663047A (de)
EP (1) EP0472399B1 (de)
JP (1) JP2560160B2 (de)
CA (1) CA2049449C (de)
DE (1) DE69130845T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06505391A (ja) * 1991-03-06 1994-06-23 リージェント　オブ　ザ　ユニバーシティー　オブ　ミネソタ Ｄｎａ配列化に基づくｈｌａタイピング
US5976789A (en) * 1991-07-17 1999-11-02 Bio Merieux System of probes enabling HLA-DR typing to be performed, and typing method using said probes
FR2679252B1 (fr) † 1991-07-17 1993-12-10 Bio Merieux Systeme de sondes permettant d'effectuer le typage hla dr, et procede de typage utilisant lesdites sondes.
FR2749308B1 (fr) * 1996-06-03 1998-07-24 Bio Merieux Sondes nucleotidiques et procede pour determiner le typage hla dqb1
DE19627290A1 (de) * 1996-07-06 1998-01-08 Boehringer Mannheim Gmbh Bestimmung von Analyten unter Verwendung zweier Markierungen
WO1998036091A1 (en) * 1997-02-14 1998-08-20 Medical Research Council Method of determining susceptibility to late-onset alzheimer's disease and dementia with lewy bodies
EP0953650A1 (de) 1998-04-20 1999-11-03 Innogenetics N.V. Verfahren für die HLA Typisierung
EP1536021A1 (de) * 2003-11-27 2005-06-01 Consortium National de Recherche en Genomique (CNRG) Methode zur Typisierung von HLA
EP2073383B1 (de) 2007-12-19 2011-08-10 Sequans Communications Verstärkeranordnung
JP2010162020A (ja) * 2008-12-15 2010-07-29 Wakunaga Pharmaceut Co Ltd 新規ｈｌａ−ｄｒｂ１遺伝子およびその用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4835098A (en) * 1985-09-04 1989-05-30 Regents Of University Of Minnesota Characterization of HLA alleles with locus-specific DNA probes
US6194561B1 (en) * 1986-03-13 2001-02-27 Roche Molecular Systems, Inc. Characterization and detection of sequences associated with autoimmune diseases
US5013649A (en) * 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US4917999A (en) * 1986-09-02 1990-04-17 Miles Inc. Oligonucleotide probes for detection of α-amylase genes
US5026837A (en) * 1987-05-04 1991-06-25 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University DNA probe which reveals a hypervariable region on human chromosome 16
US4956281A (en) * 1987-06-03 1990-09-11 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3

Also Published As

Publication number Publication date
US5663047A (en) 1997-09-02
CA2049449A1 (en) 1992-02-21
DE69130845D1 (de) 1999-03-18
EP0472399A2 (de) 1992-02-26
EP0472399B1 (de) 1999-02-03
JP2560160B2 (ja) 1996-12-04
CA2049449C (en) 1999-08-10
JPH05276954A (ja) 1993-10-26
EP0472399A3 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
DE69227076T2 (de) In-situ-PCR-Präparationen und Verwendung.
DE69223476D1 (de) Cermets, ihre Herstellung und Verwendung
FI924188A0 (fi) Platsspecifik spjaelkning av en enkelstraengad dna.
DE3787590D1 (de) Polytetrafluoraethylenhaltige beschichtungsmasse und ihre verwendung.
DE69620270D1 (de) Backfett und dessen Verwendung
DE59709806D1 (de) Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
DE68903665D1 (de) Balg-pipette und ihre verwendung.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
BR9401355A (pt) Oligonucleotídeo e nucleotídeo.
DE68906462D1 (de) Praeparat aus reiskleie und dessen verwendung.
DE69130845T2 (de) HLA-DR Antigen-Gen, dessen Nukleotidsequenz und Verwendung
NO913814D0 (no) Innskudd av dna med modifiserte transposoner.
DE58904018D1 (de) Enantiomere silane, modifiziertes traegermaterial und dessen verwendung.
DE3881099D1 (de) Acrylkautschuk, zusammensetzung aus acrylkautschuk und gegenstaende aus vernetztem acrylkautschuk.
DE68919259D1 (de) N-Phenylimide, ihre Herstellung und Verwendung.
DE58904019D1 (de) Enantiomere silane, modifiziertes traegermaterial und dessen verwendung.
DE3883352T2 (de) Muramylpeptid-Derivate und ihre Verwendung.
DE59005524D1 (de) Widerstandsmasse und ihre Verwendung.
DE3786578D1 (de) Biotin-synthetase kodierendes gen und dessen verwendung.
ATE125534T1 (de) Substituierte dibenzonfurane und ihre verwendung.
DE69301018D1 (de) Menschliches Glycosyltransferase Gen
DE69012142D1 (de) Acylierte bradykininantagonisten und deren verwendung.
DE69011218D1 (de) Gasheizgerät.
DE69004808D1 (de) Antibiotikum N-Acetylbenanomicin B, dessen Herstellung und Verwendung.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee